Showing 781 - 800 results of 99,402 for search '(( 5 ((026 decrease) OR (a decrease)) ) OR ( 5 ((non decrease) OR (nn decrease)) ))', query time: 1.60s Refine Results
  1. 781
  2. 782
  3. 783

    Selectivity of PRMT5 inhibition with C220. by Shelby L. Sloan (10803222)

    Published 2021
    “…For all cell lines, effects of PRMT5 inhibition with C220 treatment on biomarkers of PRMT5 activity shows a dose-dependent decrease in global marks of symmetric di-methylarginine (SDMA) and symmetric di-methylation of histone H4 arginine-3 (H4R3me2s) with a minimal effect to PRMT5 or global asymmetric di-methylarginine (ADMA). …”
  4. 784
  5. 785

    Genes correlated with SARS-CoV-2 viral load over time are similarly expressed in independent datasets of SARS-CoV-2 infected lung and upper airway cells. by Vasanthi Avadhanula (259546)

    Published 2025
    “…<p><b>(a)</b> Differential expression patterns for the 112 genes correlated with SARS-CoV-2 viral load across our serial sampling cohort (p<0.001, from <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0317033#pone.0317033.g003" target="_blank">Fig 3A</a>) were examined in two independent RNA-seq datasets of SARS-CoV-2 infection: one of lung cancer cell lines (A549 and Calu-3) infected with SARS-CoV-2 at multiplicity-of-Infection (MOI) of 2 for 24 hours (in biological triplicate)[<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0317033#pone.0317033.ref028" target="_blank">28</a>], and one of nasopharyngeal/oropharyngeal samples in 238 patients with COVID-19, other viral, or non-viral acute respiratory illnesses [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0317033#pone.0317033.ref029" target="_blank">29</a>]. …”
  6. 786
  7. 787
  8. 788

    A decrease in circulating CXCR5+CD4+ Tfh cells is associated with HCC progression, and CXCR5+CD4+ Tfh cells are decreased in tumor regions. by Yiqiong Jia (692871)

    Published 2015
    “…<p>(A) The prevalence of CXCR5+CD4+ Tfh cells decreases with progressive stages in HCC. …”
  9. 789

    Table_1_Manipulation of an α-glucosidase in the industrial glucoamylase-producing Aspergillus niger strain O1 to decrease non-fermentable sugars production and increase glucoamylas... by Wenzhu Guo (501328)

    Published 2022
    “…Improving glucose yield and decreasing the non]-fermentable sugars which caused by transglycosylation activity of the enzymes during the starch saccharification is an important direction. …”
  10. 790
  11. 791
  12. 792

    Effects of Wnt11 and Wnt5a in tumour development. by Domokos Bartis (364771)

    Published 2013
    “…Only the rWnt5a treated SAEC migrated faster than the non-treated control cells. …”
  13. 793
  14. 794
  15. 795
  16. 796

    Comparison of potential energy minimization curves of hypothetical monomer chains from non-capsid and capsid dimers. by Weimin Wu (505435)

    Published 2020
    “…<p>Compared are apo 3KXS (A) and liganded 5E0I (B) non-capsid chains with the apo T = 4 1QGT capsid chains (C). …”
  17. 797
  18. 798
  19. 799

    Decreases in white matter integrity in t(1;11) translocation carriers (n = 7) versus non-carriers (n = 13) and in patients (n = 34) versus controls (n = 33). by Heather C. Whalley (287657)

    Published 2015
    “…To aid visualization the results (pfwe < 0.05) are thickened using the “tbss-fill” command. Statistics for FA decreases in the patient group versus controls for these peaks; cluster 1: p = 0.023 at [-3, 28, 6; left genu of corpus callosum], cluster 2: p = 0.032 at [29, 26, 15; right fronto-occipital fasciculus], cluster 3: p = 0.012 at [11, 26, 14; right genu of corpus callosum], cluster 4: p = 0.033 at [20, 25, 0; right acoustic radiation], and cluster 5: p = 0.031 at [28, -24, -8; right fornix] i.e. for clusters 1–5 respectively, see, <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0130900#pone.0130900.t002" target="_blank">Table 2</a>).…”
  20. 800

    Taurine signaling via GABRA5 affects survival of cholangiocarcinoma patients. by Camiel L. C. Wielders (5250050)

    Published 2018
    “…<p><b>(A)</b> Expression of GABRA5, GABRB3 and TUG1 in expanding liver progenitor cells (blue), differentiated hepatocytes (red) and cholangiocytes (yellow) (Shin et al., 2011). …”